Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TPM3 |
| Upstream (Parents) |
|---|
| (<<) ACTC1 → TPM3 |
| (<<) CD3EAP → TPM3 |
| (<<) COX6A2 → TPM3 |
| (<<) CSF2 → TPM3 |
| (<<) DUSP5 → TPM3 |
| (<<) EPHA2 → TPM3 |
| (<<) HIST3H3 → TPM3 |
| (<<) HPS6 → TPM3 |
| (<<) MYL3 → TPM3 |
| (<<) NFATC4 → TPM3 |
| (<<) PLD2 → TPM3 |
| (<<) TPM1 → TPM3 |
| (<<) TPM2 → TPM3 |
| (<<) TSPO → TPM3 |
| Downstream (Children) |
|---|
| TPM3 → ACTN3 (>>) |
| TPM3 → DHRS9 (>>) |
| TPM3 → NAB2 (>>) |
| TPM3 → TPSG1 (>>) |
